top of page
National Cancer Patient Experience Survey 2014
The National Cancer Patient Experience Survey 2014 was published this morning. Our comment on its publication is here.
Cancer52 publishes Manifesto for the 2015 General Election
Cancer52, an alliance of 80 charities working in the field of rare and less common cancers is today (19th September 2014) publishing its...
Joint VBA Statement
The Joint VBA Statement, prepared alongside Genetic Alliance UK, which nearly half our members signed, was submitted on Friday 12th...
Cancer52 response to announcement of new investment for Cancer Drugs Fund
Cancer52 welcomes the new additional investment of £160 million in the Cancer Drugs Fund (CDF) announced by Health Secretary Jeremy Hunt...
Cancer52 response to the NICE consultation
Please find here Cancer52's response to the NICE Methods of Technology Appraisal Consultation, which was submitted to NICE on Tuesday...
Clara Mackay appointed as interim chair of Cancer52
Cancer52 is delighted to announce that Clara Mackay, Deputy CEO of Pancreatic Cancer UK, has been appointed as interim chair of Cancer52....
Cancer52 responds to NICE consultation on Technology Appraisals Process Guide
On the basis of the increasing experience of our members with NICE Technology Appraisals Cancer52 has commented in detail on a number of...
Cancer52 publishes briefing paper on the UK Strategy for Rare Diseases
Making sure that rare cancers aren’t written out of the script Cancer52 published its briefing paper on the UK Strategy for Rare...
Cancer52 publishes briefing paper on NICE and Value Based Assessment (VBA)
Cancer52 published its briefing paper "NICE and Value Based Assessment (VBA) - NICE do it their way." NICE is due to consult on its...
Cancer52 welcomes NCIN Routes to Diagnosis research
The National Cancer Intelligence Network (NCIN) has published new research on Routes to Diagnosis (RtD) for 55 cancer sites or groups,...
bottom of page